Veru Inc Avanti P/E
Cos'è Avanti P/E di Veru Inc?
Avanti P/E di Veru Inc è -0.88
Qual è la definizione di Avanti P/E?
Il rapporto prezzo / utili a termine è il rapporto tra il prezzo delle azioni di una società e l'utile stimato per azione della società per i prossimi dodici mesi.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Avanti P/E di aziende nel Health Care settore su NASDAQ rispetto a Veru Inc
Cosa fa Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Aziende con avanti p/e simili a Veru Inc
- GEN III Oil ha Avanti P/E di -0.91
- Top Ships Inc ha Avanti P/E di -0.91
- Diffusion Pharmaceuticals Inc ha Avanti P/E di -0.90
- Viking ha Avanti P/E di -0.90
- Sangamo Therapeutics Inc ha Avanti P/E di -0.90
- Sol-Gel Technologies Ltd ha Avanti P/E di -0.90
- Veru Inc ha Avanti P/E di -0.88
- Thin Film Electronics ASA ha Avanti P/E di -0.87
- Enertime SA ha Avanti P/E di -0.86
- Minerva Neurosciences Inc ha Avanti P/E di -0.85
- Centogene NV ha Avanti P/E di -0.85
- Check-Cap Ltd ha Avanti P/E di -0.84
- Bonavista ha Avanti P/E di -0.83